1. Home
  2. BTMD vs PYPD Comparison

BTMD vs PYPD Comparison

Compare BTMD & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.17

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.39

Market Cap

86.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
PYPD
Founded
2012
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
86.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BTMD
PYPD
Price
$2.17
$4.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$2.83
$12.25
AVG Volume (30 Days)
199.3K
41.3K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
722.22
N/A
EPS
0.74
N/A
Revenue
$192,219,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$2.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$2.44
52 Week High
$4.75
$5.12

Technical Indicators

Market Signals
Indicator
BTMD
PYPD
Relative Strength Index (RSI) 58.16 45.31
Support Level $2.02 $4.29
Resistance Level $2.20 $5.05
Average True Range (ATR) 0.12 0.20
MACD -0.02 -0.03
Stochastic Oscillator 54.15 19.23

Price Performance

Historical Comparison
BTMD
PYPD

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: